PiC transgenic mice with elevated and shRNA mediated diminished levels of cardiac PiC have been characterized by cardiac hypertrophy, unaltered respiration, ATP content, Ca2+ retention, and activation of the MPTP (Gutiérrez-Aguilar et al., 2014). Here, SLC25A3 is linked to cardiac hypertrophy.